98 related articles for article (PubMed ID: 1335941)
1. VIP inhibits CCK-induced gallbladder contraction involving a beta-adrenoceptor mediated pathway in the rainbow trout, Oncorhynchus mykiss, in vivo.
Aldman G; Holmgren S
Gen Comp Endocrinol; 1992 Nov; 88(2):287-91. PubMed ID: 1335941
[TBL] [Abstract][Full Text] [Related]
2. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
Ryan JP; Ryave S
Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
[TBL] [Abstract][Full Text] [Related]
3. Interactions of vasoactive intestinal polypeptide and cholecystokinin octapeptide on the control of gallbladder contraction.
Strah KM; Melendez RL; Pappas TN; Debas HT
Surgery; 1986 Apr; 99(4):469-73. PubMed ID: 3952671
[TBL] [Abstract][Full Text] [Related]
4. Intraduodenal fat and amino acids activate gallbladder motility in the rainbow trout, Oncorhynchus mykiss.
Aldman G; Holmgren S
Gen Comp Endocrinol; 1995 Oct; 100(1):27-32. PubMed ID: 8575655
[TBL] [Abstract][Full Text] [Related]
5. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure.
Ryan J; Cohen S
Gastroenterology; 1977 Oct; 73(4 Pt 1):870-2. PubMed ID: 892388
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of rainbow trout gallbladder contraction by cionin, an ancestral member of the CCK/gastrin family.
Schjoldager B; Jørgensen JC; Johnsen AH
Gen Comp Endocrinol; 1995 Jun; 98(3):269-78. PubMed ID: 7628686
[TBL] [Abstract][Full Text] [Related]
7. Regulation of canine gallbladder motility by brain peptides.
Lenz HJ; Zimmerman FG; Messmer B
Gastroenterology; 1993 Jun; 104(6):1678-85. PubMed ID: 8500726
[TBL] [Abstract][Full Text] [Related]
8. The vagal nerves and peptides in the control of extrahepatic biliary motility. An experimental study in the cat.
Dahlstrand C
Acta Physiol Scand Suppl; 1990; 589():1-52. PubMed ID: 1700577
[TBL] [Abstract][Full Text] [Related]
9. Effects of cholecystokinine on the gallbladder motility: interaction with somatostatin and vasoactive intestinal peptide.
Milenov K; Rakovska A; Kalfin R
Acta Physiol Pharmacol Bulg; 1995; 21(3):67-76. PubMed ID: 8868369
[TBL] [Abstract][Full Text] [Related]
10. Duodenal acidification and intra-arterial injection of CCK8 increase gallbladder motility in the rainbow trout, Oncorhynchus mykiss.
Aldman G; Grove D; Holmgren S
Gen Comp Endocrinol; 1992 Apr; 86(1):20-5. PubMed ID: 1505726
[TBL] [Abstract][Full Text] [Related]
11. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro.
Lonovics J; Devitt P; Rayford PL; Thompson JC
Surg Forum; 1979; 30():407-9. PubMed ID: 538649
[No Abstract] [Full Text] [Related]
12. The effect of vasoactive intestinal polypeptide (VIP) on the canine gallbladder motility.
Kalfin R; Milenov K
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(3):513-7. PubMed ID: 1687549
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat.
Jansson R; Steen G; Svanvik J
Gastroenterology; 1978 Jul; 75(1):47-50. PubMed ID: 401095
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cholecystokinin receptors on the human gallbladder.
Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide.
Vergara P; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE
J Pharmacol Exp Ther; 1996 Oct; 279(1):306-16. PubMed ID: 8859008
[TBL] [Abstract][Full Text] [Related]
16. Effect of endogenous cholecystokinin on postprandial gallbladder refilling. Ultrasonographic study in healthy subjects and in gallstone patients.
Cicala M; Corazziari E; Diacinti D; Badiali D; Torsoli A
Dig Dis Sci; 1995 Jan; 40(1):76-81. PubMed ID: 7821124
[TBL] [Abstract][Full Text] [Related]
17. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
Otto B; Mawe GM; Riepl RL
Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
[TBL] [Abstract][Full Text] [Related]
18. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
[TBL] [Abstract][Full Text] [Related]
19. Gallbladder muscle dysfunction in patients with chronic acalculous disease.
Amaral J; Xiao ZL; Chen Q; Yu P; Biancani P; Behar J
Gastroenterology; 2001 Feb; 120(2):506-11. PubMed ID: 11159891
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of PACAP on guinea pig gallbladder muscle via PACAP-preferring and VIP/PACAP-preferring receptors.
Parkman HP; Pagano AP; Ryan JP
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1433-8. PubMed ID: 9227479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
